Jessica Hagen
The company also released its Q1 2023 earnings, showing increased revenue of $311.1 million with a net loss of $63.2 million.
The feature monitors heart rhythms suggestive of atrial fibrillation through the Galaxy Watch.
Patients in Emory's behavioral health program will utilize NeuroFlow's platform to have access to psychotherapy content between scheduled visits.
This is the second round of layoffs in less than a year.
In a blog post, the virtual care provider blasts the insurer for paying it less than other providers in California and refusing to process 'every single' out-of-network claim.
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The company reported $33.3 million in revenue for Q1 2023 and a net loss of $8.8 million.
Users will have the option to participate in groups and schedule a coaching session.
The Boston-based company will use the investment to accelerate growth and expand its platform.